TESTAGEN

Synthetic Peptide for Testicular Bioregulator Research

Technical Overview

Testagen 20mg is a synthetic peptide compound developed for laboratory research involving testicular gene expression and short-peptide bioregulator activity, receptor interaction analysis, and controlled experimental investigation. In research settings, this peptide is commonly utilized for studying testicular cell signaling, hormone-related transcription factor activity, and related biochemical mechanisms. Testagen is a Khavinson-class short-peptide bioregulator with the sequence L-Lys-L-Glu-L-Asp-L-Gly (KEDG), originally derived from analysis of testicular tissue extracts by Prof. Vladimir Khavinson's research group. Short peptides in this class are hypothesized to interact with DNA in a sequence-specific manner, modulating gene expression within their tissue of origin. Testagen shares three of four residues with Livagen, substituting glycine for alanine at the C-terminus, which is associated with testicular-tissue specificity within the Khavinson framework.

Specifications

Sequence: L-Lys-L-Glu-L-Asp-L-Gly (KEDG) Molecular Formula: C₁₇H₂₉N₅O₉ Molecular Weight: ~447 g/mol Purity: ≥ 99% CAS: 1026993-38-3 Form: Lyophilized powder

Research Use Only

This product is intended for laboratory research purposes only and is not for human or veterinary use, diagnostic procedures, or therapeutic application.